Related Experiment Videos
Mutation in GM2-gangliosidosis B1 variant.
1Department of Neurology, University of North Carolina, School of Medicine, Chapel Hill 27599-7250.
Journal of Neurochemistry
|January 1, 1988
Summary
Researchers identified a specific gene mutation in GM2-gangliosidosis B1 variant, impacting beta-hexosaminidase alpha subunit production and enzyme structure. This finding offers new insights into enzyme function and genetic disease mechanisms.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- GM2-gangliosidosis B1 variant is a rare genetic disorder.
- Defects in the beta-hexosaminidase alpha subunit are implicated in this condition.
- Understanding the molecular basis is crucial for disease research.
Purpose of the Study:
- To investigate the molecular defect in beta-hexosaminidase alpha subunit in a patient with GM2-gangliosidosis B1 variant.
- To identify the specific genetic mutation responsible for the disease phenotype.
- To analyze the potential impact of the mutation on enzyme structure and function.
Main Methods:
- Analysis of fibroblast mRNA for beta-hexosaminidase alpha subunit.
- Nucleotide sequencing of cDNA clones encoding the alpha subunit.
- Computer-based prediction of protein structure alterations.
Main Results:
- Fibroblasts showed reduced mRNA quantity for the beta-hexosaminidase alpha subunit.
- A single G-to-A base substitution at nucleotide 533 was identified, changing arginine to histidine at amino acid 178.
- This mutation, located near the N-terminus, was predicted to cause significant changes in enzyme secondary structure.
Conclusions:
- A novel mutation in the beta-hexosaminidase alpha subunit gene is associated with GM2-gangliosidosis B1 variant.
- The identified mutation likely disrupts enzyme structure and function.
- These findings contribute to understanding the functional domains of beta-hexosaminidase.